3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Drug News - Eye / Vision Problems -

FDA approves combo eye drop for glaucoma

Drug News • • Eye / Vision ProblemsOct 31, 07

U.S. regulators approved a new glaucoma treatment—Combigan, an eye drop that treats the potentially blinding eye condition with two drugs that work through different mechanisms, Allergan Inc said Wednesday.

Allergan, best known for its Botox anti-wrinkle drug but is also a leading provider of eye medications and products, said its new drug would be introduced in the fourth quarter of 2007.

The company said Combigan would combine “two strong agents in one bottle”—brimonidine and timolol—to control pressure within the eye that can harm the optic nerve.

Print Version
comments powered by Disqus

  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  UGA ecologist finds another cause of antibiotic resistance
  New drug for neuroblastoma shows promise in phase I study
  Baclofen shows promise in patients with alcohol-induced liver disease
  Joslin researchers find drugs are effective for diabetic macular edema in new trial
  Findings point to an ‘off switch’ for drug resistance in cancer
  Stopping statins may benefit terminally ill patients
  Cholesterol drug users may use pills as a license to overeat
  Pfizer lung cancer drug beats chemo for previously untreated patients
  Mass. General study identifies path to safer drugs for heart disease, cancer
  Gates Foundation awards Notre Dame $23 million for malaria, dengue studies
  In the blink of an eye


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site